The global left atrial appendage closure (LAAC) devices market is projected to register a robust growth from 2025 to 2033. Market growth is underpinned by a rapidly expanding AFib patient population, ...

Global materials science company W. L. Gore & Associates has reached an agreement to acquire Conformal Medical, a medtech ...

W.L. Gore & Associates announced today that it agreed to acquire left atrial appendage occlusion (LAAO) device maker ...

Study will assess the Company's Next-Generation device under Intracardiac Echocardiography (ICE) imaging for Left Atrial Appendage Occlusion (LAAO) procedures. "Simplified sizing and ease of use ...

New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation ...

Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation. Left atrial appendage occlusion (LAAO) placement is associated with a reduced risk for ...

Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...

CHICAGO -- For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure led to less bleeding compared with oral anticoagulation, the ...

FORT MILL, SC / ACCESSWIRE / February 26, 2024 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a US based medical device company focused on novel electrophysiology products, announced ...

Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation The trial met the primary safety ...

Researchers have found in a new study that adding Left Atrial Appendage Occlusion (LAAO) during cardiac surgery in patients ...